Aldeyra Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALDX and other ETFs, options, and stocks.

About ALDX

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases.

CEO

Todd C. Brady

CEOTodd C. Brady

Employees

Employees9

Headquarters

Lexington, Massachusetts

HeadquartersLexington, Massachusetts

Founded

2004

Founded2004

Employees

Employees9

ALDX Key Statistics

Market cap

299.48M

Market cap299.48M

Price-Earnings ratio

-5.85

Price-Earnings ratio-5.85

Dividend yield

—

Dividend yield—

Average volume

921.90K

Average volume921.90K

High today

$5.11

High today$5.11

Low today

$4.88

Low today$4.88

Open price

$4.97

Open price$4.97

Volume

485.10K

Volume485.10K

52 Week high

$7.20

52 Week high$7.20

52 Week low

$1.14

52 Week low$1.14

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own ALDX. This list is generated using Robinhood data, and it’s not a recommendation.

Aldeyra Therapeutics

Why Robinhood?

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. Show more

ALDX Key Statistics

Analyst ratings

100%

People also own

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases.